Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days agoNovavax stock isn't a buy. Savvy investors are encouraged to buy a stock after it breaks out of a...
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 4 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 5 days agoThose concerns are now alleviated as Novavax has agreed to refund up to $475 million. More recently, there was news that Novavax entered ...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 4 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment
InvestorPlace· 11 hours agoIt was not long ago that Novavax (NASDAQ:NVAX) was among the stocks with high short interest. In the...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoBut the good news is that the newly dominant variants don’t appear more likely to cause severe...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 21 hours agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 days agoPer Zambrano, all three COVID vaccine manufacturers—Pfizer, Moderna, and Novavax—have said that...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 5 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...